| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia
|
Fozza, Claudio
|
|
2015
|
39 |
9 |
p. 957-963
7 p.
|
artikel
|
| 2 |
Differential changes in sphingolipids between TNF-induced necroptosis and apoptosis in U937 cells and necroptosis-resistant sublines
|
Sawai, Hirofumi
|
|
2015
|
39 |
9 |
p. 964-970
7 p.
|
artikel
|
| 3 |
Editorial board and publication information
|
|
|
2015
|
39 |
9 |
p. IFC-
1 p.
|
artikel
|
| 4 |
Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition
|
Drusbosky, Leylah
|
|
2015
|
39 |
9 |
p. 984-989
6 p.
|
artikel
|
| 5 |
High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
|
Ahmed, Tamjeed
|
|
2015
|
39 |
9 |
p. 945-949
5 p.
|
artikel
|
| 6 |
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
|
Kharfan-Dabaja, Mohamed A.
|
|
2015
|
39 |
9 |
p. 933-937
5 p.
|
artikel
|
| 7 |
Mechanism of the inhibition of leukemia cell growth and induction of apoptosis through the activation of ATR and PTEN by the topoisomerase inhibitor 3EZ, 20Ac-ingenol
|
Miyata, Shohei
|
|
2015
|
39 |
9 |
p. 927-932
6 p.
|
artikel
|
| 8 |
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients
|
Chen, Cai
|
|
2015
|
39 |
9 |
p. 990-1001
12 p.
|
artikel
|
| 9 |
Prognostic factors of patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide-based frontline therapy
|
Lou, Yinjun
|
|
2015
|
39 |
9 |
p. 938-944
7 p.
|
artikel
|
| 10 |
The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma
|
Andersen, Morten N.
|
|
2015
|
39 |
9 |
p. 971-975
5 p.
|
artikel
|
| 11 |
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase
|
Badar, Talha
|
|
2015
|
39 |
9 |
p. 950-956
7 p.
|
artikel
|
| 12 |
Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells
|
Chen, Shuying
|
|
2015
|
39 |
9 |
p. 976-983
8 p.
|
artikel
|
Tijdschrift beschrijving